Home ›
Trademark Categories ›
Pharmaceuticals ›
2015 ›
BI ›
BINCREDO
Trademark search for:
BINCREDO
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2015-06-12 — Application filed
2015-06-16 — Application filed
2015-06-16 — Application filed
2015-09-16 — Assigned to examiner
2015-09-21 — Final disposition recorded
2015-09-21 — Final disposition recorded
2015-09-21 — Final disposition recorded
2015-10-19 — Office action issued
2015-10-19 — Correspondence received in law office
2015-10-19 — Teas/email correspondence entered
2015-11-06 — Suspension letter written
2015-11-06 — Letter of suspension e-mailed
2015-11-06 — Notification of letter of suspension e-mailed
2016-05-10 — Assigned to lie
2016-05-10 — Report completed suspension check case still suspended
2016-11-14 — Report completed suspension check case still suspended
2017-05-16 — Suspension checked - to attorney for action
2017-05-24 — Final disposition recorded
2017-05-24 — Final disposition recorded
2017-05-24 — Final disposition recorded
2017-10-27 — Office action issued
2017-10-27 — Correspondence received in law office
2017-10-27 — Teas/email correspondence entered
2017-11-20 — Office action issued
2017-11-20 — Office action issued
2017-11-20 — Office action issued
2018-01-03 — Examiners amendment -written
2018-01-03 — Examiner's amendment entered
2018-01-03 — Examiners amendment e-mailed
2018-01-03 — Notification of examiners amendment e-mailed
2018-01-03 — Approved for pub - principal register
2018-01-17 — Notification of notice of publication e-mailed
2018-02-06 — Published for opposition
2018-02-06 — Official gazette publication confirmation e-mailed
2018-04-03 — Noa e-mailed - sou required from applicant
2018-09-30 — Sou teas extension received
2018-09-30 — Sou extension 1 filed
2018-09-30 — Sou extension 1 granted
2018-10-02 — Notice of approval of extension request e-mailed
2019-04-01 — Sou teas extension received
2019-04-01 — Sou extension 2 filed
2019-04-01 — Sou extension 2 granted
2019-04-03 — Notice of approval of extension request e-mailed
2019-09-29 — Sou teas extension received
2019-09-29 — Sou extension 3 filed
2019-09-29 — Sou extension 3 granted
2019-10-01 — Notice of approval of extension request e-mailed
2020-03-29 — Sou teas extension received
2020-03-29 — Sou extension 4 filed
2020-03-29 — Sou extension 4 granted
2020-03-31 — Notice of approval of extension request e-mailed
2020-09-30 — Sou teas extension received
2020-09-30 — Sou extension 5 filed
2020-10-05 — Case assigned to intent to use paralegal
2020-10-05 — Sou extension 5 granted
2020-10-06 — Notice of approval of extension request e-mailed
2020-12-18 — Assigned to examiner
2021-05-10 — Application abandoned
2021-05-10 — Application abandoned
2021-05-10 — Final status recorded
2024-05-16 — Assigned to examiner
Owner Information
Novartis AG
Basel CH
Novartis AG
Basel CH
Correspondent
Maury M. Tepper, III Tepper & Eyster Pllc 3724 Benson Dr Raleigh, NC 27609-7321 UNITED STATES
Filing Details
Filing Date:
2015-06-12
Status Date:
2021-05-10
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.